Shiraki M - Search Results

1

Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.

Earhart RH, Amato DJ, Chang AY, Borden EC, Shiraki M, Dowd ME, Comis RL, Davis TE, Smith TJ. Earhart RH, et al. Among authors: shiraki m. Invest New Drugs. 1990 Feb;8(1):113-9. doi: 10.1007/BF00216936. Invest New Drugs. 1990. PMID: 2188926 Clinical Trial.

2

Phase II trials of interferons-alpha and -beta in advanced sarcomas.

Borden EC, Kim K, Ryan L, Blum RH, Shiraki M, Tormey DC, Comis RL, Hahn RG, Parkinson DR. Borden EC, et al. Among authors: shiraki m. J Interferon Res. 1992 Dec;12(6):455-8. doi: 10.1089/jir.1992.12.455. J Interferon Res. 1992. PMID: 1289413 Clinical Trial.

3

Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.

Borden EC, Amato DA, Edmonson JH, Ritch PS, Shiraki M. Borden EC, et al. Among authors: shiraki m. Cancer. 1990 Sep 1;66(5):862-7. doi: 10.1002/1097-0142(19900901)66:5<862::aid-cncr2820660509>3.0.co;2-r. Cancer. 1990. PMID: 2201431 Clinical Trial.

4

Phase II trial of carboplatin in soft-tissue sarcoma.

Goldstein D, Cheuvart B, Trump DL, Shiraki M, Comis RL, Tormey DC, Harris JE, Borden EC. Goldstein D, et al. Among authors: shiraki m. Am J Clin Oncol. 1990 Oct;13(5):420-3. doi: 10.1097/00000421-199010000-00011. Am J Clin Oncol. 1990. PMID: 2220662 Clinical Trial.

5

Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma.

Amato DA, Borden EC, Shiraki M, Enterline HT, Rosenbaum C, Davis HL, Paul AR, Stevens CM, Lerner HJ. Amato DA, et al. Among authors: shiraki m. Invest New Drugs. 1985;3(4):397-401. doi: 10.1007/BF00170765. Invest New Drugs. 1985. PMID: 2417985

6

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

Borden EC, Amato DA, Rosenbaum C, Enterline HT, Shiraki MJ, Creech RH, Lerner HJ, Carbone PP. Borden EC, et al. Among authors: shiraki mj. J Clin Oncol. 1987 Jun;5(6):840-50. doi: 10.1200/JCO.1987.5.6.840. J Clin Oncol. 1987. PMID: 3585441 Clinical Trial.

7

Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience.

Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, Rao UN, Enzinger FM, Amato DA, Borden EC. Shiraki M, et al. Cancer. 1989 Jul 15;64(2):484-90. doi: 10.1002/1097-0142(19890715)64:2<484::aid-cncr2820640223>3.0.co;2-t. Cancer. 1989. PMID: 2736494

8

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR. Edmonson JH, et al. Among authors: shiraki m. J Clin Oncol. 1993 Jul;11(7):1269-75. doi: 10.1200/JCO.1993.11.7.1269. J Clin Oncol. 1993. PMID: 8315424 Clinical Trial.

9

Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma.

Lerner HJ, Amato DA, Savlov ED, DeWys WD, Mittleman A, Urtasun RC, Sobel S, Shiraki M. Lerner HJ, et al. Among authors: shiraki m. J Clin Oncol. 1987 Apr;5(4):613-7. doi: 10.1200/JCO.1987.5.4.613. J Clin Oncol. 1987. PMID: 3549990 Clinical Trial.

10

Alveolar rhabdomyosarcoma. An analysis of 110 cases.

Enzinger FM, Shiraki M. Enzinger FM, et al. Among authors: shiraki m. Cancer. 1969 Jul;24(1):18-31. doi: 10.1002/1097-0142(196907)24:1<18::aid-cncr2820240103>3.0.co;2-5. Cancer. 1969. PMID: 5790286 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters